People: Research Team

Dr. Giulia Biffi –Programme Co-lead

Giulia Biffi is a UKRI Future Leaders Fellow and Group Leader at the Cancer Research UK Cambridge Institute, University of Cambridge. Her laboratory works to understand the biology of pancreatic cancer, specifically on fibroblasts and the tumour microenvironment, with aim of identifying more effective treatments for patients. 

• Photo credit: Cambridge Cancer Research Hospital


Read More

Professor Duncan Jodrell, DM MSc FRCP(Edin.) – Researcher and Medical Oncologist 

Duncan is the Professor of Cancer Therapeutics at the University of Cambridge. He is the Cambridge Experimental Cancer Medicine Centre (ECMC) Lead, Director of the Cambridge Cancer Trials Centre (CCTC) and an honorary consultant at Addenbrooke’s Hospital.

Dr. Tim Halim – Programme Training Representative

Tim is a Group Leader at the Cancer Research UK – Cambridge Institute, University of Cambridge. He obtained his PhD in 2013 at the University of British Columbia (Canada), after which he moved to the laboratory of Dr. Andrew McKenzie at the MRC Laboratory of Molecular Biology (UK) on a CIHR Banting Fellowship.

Professor Sir Stephen O’Rahilly

Stephen co-directs the Wellcome-MRC Institute of Metabolic Science (IMS) with Professor Nick Wareham. Within the IMS, he directs the MRC Metabolic Diseases Unit. He is also Head of the University Department of Clinical Biochemistry. On the wider Cambridge Biomedical Campus, he is Scientific Director of the NIHR Biomedical Research Centre and a Fellow of Pembroke College.

Professor George Malliaras

George Malliaras is the Prince Philip Professor of Technology at the University of Cambridge. He is leading the EPSRC IRC on Targeted Delivery for Hard-to-Treat Cancers and works on electrophoretic drug delivery devices.

Professor Jason Carroll

Jason Carroll is a Professor of Molecular Oncology at the University of Cambridge, a Senior Group Leader at Cancer Research UK, a Fellow at Clare College and was elected an EMBO member in 2016 and a Fellow of the Academy of Medical Sciences in 2017. His lab is interested in understanding mechanisms of hormone-dependent cancer.

Dr. Michael (Mike) Gill

Mike is a Principal Scientific Associate in the Miller lab at the Cancer Research UK- Cambridge Institute, University of Cambridge. He obtained his Ph.D. in 2000 at the University of Cambridge, after which he moved to the laboratory of Dr Joyce Fingeroth at Harvard University, and then returned to the University of Cambridge in 2005 to take a position in the Division of Virology, Department of Pathology.

Professor Kevin Brindle

Kevin is a senior group leader at the CRUK Cambridge Institute where his lab works in the field of molecular imaging.  The primary focus of their work is early detection of tumour treatment response with the aim of developing imaging methods that could be used in early phase clinical trials to get an indication of drug efficacy, and subsequently in the clinic to guide treatment in individual patients.

Dr Ljiljana Fruk

Ljiljana is Associate Professor of BioNano Engineering, teaches Bionanotechnology, Chemical Product Design and Engineering Ethics at the University of Cambridge, and is a fellow of Sidney Sussex College.

Professor Masashi Narita

Masashi is Professor of Senobiology at the University of Cambridge, a Senior Group Leader at Cancer Research UK Cambridge Institute, and a Specially Appointed Professor at the Tokyo Institute of Technology.

Professor Laura Machesky – FRSE FMedSci, Sir William Dunn Professor of Biochemistry, University of Cambridge

Professor Laura Machesky is currently the Sir William Dunn Professor of Biochemistry, having recently moved to Cambridge from the University of Glasgow. Her group uses cell biology and pancreatic cancer models to study actin dynamics, adhesion and membrane trafficking and how these fundamental cell processes guide migration, cancer invasion and metastasis.